bevacizumab

Explore academic connections and research related to this keyword

266
Views
105
Total Connections

Related Articles & Bibliographies

2
Pharmaceutical diversification via palladium oxidative addition complexes.
Uehling, Mycah R;King, Ryan P;Krska, Shane W;Cernak, Tim;Buchwald, Stephen L;
2019 science (new york, ny) DOI: 10.1126/science.aac6... 241 views
3
A severe case of bevacizumab-induced thrombotic microangiopathy.
Bektas, Mert;Samancı, Nilay S;Cokgezer, Simay;Keskin, Dilek;Demirelli, Fuat H;
2019 Journal of oncology pharmacy practice : official p... DOI: 10.1177/107815521880... 201 views
4
Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer.
Hamid, Mohsin;Ghani, Ali;Micaily, Ida;Sarwar, Usman;Lashari, Bilal;Malik, Faizan;
2018 journal of community hospital internal medicine pe... DOI: 10.1080/20009666.201... 286 views
5
Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study.
Motoo, Nagane;Hayashi, Yasuko;Shimizu, Ayaka;Ura, Masako;Nishikawa, Ryo;
2019 japanese journal of clinical oncology DOI: 10.1093/jjco/hyz125 287 views
6
Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323.
Kozuki, Toshiyuki;Nogami, Naoyuki;Hataji, Osamu;Tsunezuka, Yoshio;Seki, Nobuhiko;Harada, Toshiyuki;F...
2020 translational lung cancer research DOI: 10.21037/tlcr.2020.0... 260 views
7
Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab
Doan T. M. Ngo;Trent Williams;Sophie Horder;Leonard Kritharides;Janette Vardy;Hiren Mandaliya;Ina...
2020 journal of clinical medicine DOI: 10.3390/jcm9082664 310 views
8
all india ophthalmological society members' survey: practice pattern of intravitreal anti-vascular endothelial growth factor injection
;Dheepak Sundar;Taraprasad Das;Jay Chhablani;Atul Kumar;Namrata Sharma
2020 Bioinformatics DOI: 10.4103/ijo.IJO_1602... 291 views
9
spectral domain optical coherence tomography morphology in optic disc pit associated maculopathy
;Janusz Michalewski;Zofia Michalewska;Jerzy Nawrocki
2014 Bioinformatics DOI: 10.4103/0301-4738.13... 447 views
10
loop myopexy with true muscle transplantation for very large angle heavy eye syndrome patient
;Jitendra Jethani;Sonal Amin
2015 Bioinformatics DOI: 10.4103/0301-4738.15... 308 views
11
shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma
;Thomas Simon;Sotiria Pinioti;Pascale Schellenberger;Vinothini Rajeeve;Franz Wendler;Pedro R. Cutill...
2018 ieee security and privacy DOI: 10.1186/s12943-018-0... 256 views
12
use of a combination of Аvastin and low-dose interferon- α in the first-line treatment of metastatic renal-cell cancer
;A. S. Kalpinsky;B. Ya. Alekseyev;A. D. Kaprin
2014 supportive care in cancer 161 views
15
circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens
;Antonia Martinetti;Rosalba Miceli;Elisa Sottotetti;Maria Di Bartolomeo;Filippo de Braud;Arpine Gevo...
2014 The Journal of investigative dermatology DOI: 10.3390/cancers60317... 190 views
16
utilización del bevacizumab en la neovascularización corneal use of bevacizumab in corneal neovascularization
;Taimi Cárdenas Díaz;Rosario Torres Ortegas;Yeni Corcho Arévalo;Dunia Cruz Izquierdo;Armando Capote...
2012 journal of the chinese chemical society 180 views
17
metastatic renal cell carcinoma: a guide to therapy based on current evidence
;Choueiri Toni
2009 European journal of pharmaceutical sciences : offi... 226 views
18
an unusual case of self-inflicted multiple needles injuries to eye
;Shweta Gaur;H K Bist;Vishal Sinha;Mausam Gupta
2013 Bioinformatics DOI: 10.4103/0301-4738.11... 262 views
19

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.